CT-derived ECV (odds ratio [OR]: 1.214, 95% confidence interval [CI]: 1.067–1.381, p = 0.003), mFLR ratio (OR: 0.897, 95% CI: 0.852–0.944, p < 0.001), and serum Alb (OR: 0.923, 95% CI: 0.855–0.997, p = 0.043) were independent predictors for PHLF in patients with resectable HCC (Table 3). The gene discussed is ALB; the disease is hepatocellular carcinoma.